Literature DB >> 10747823

Molecular epidemiology of an outbreak due to IRT-2 beta-lactamase-producing strains of Klebsiella pneumoniae in a geriatric department.

D Girlich1, A Karim, L Poirel, M H Cavin, C Verny, P Nordmann.   

Abstract

In February 1998, 195 patients in the geriatric department of a French hospital were screened for the presence of co-amoxiclav-resistant Klebsiella pneumoniae. Eleven co-amoxiclav-resistant isolates obtained all produced an identical IRT-2 beta-lactamase. These K. pneumoniae isolates were clonally related and harboured a c. 55 kb non-conjugative plasmid encoding a non-class-1 integron-located blaIRT-2 gene. This study underlines that geriatric departments may be a reservoir for antibiotic-resistant strains and that IRT beta-lactamase-producing strains may be nosocomial pathogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747823     DOI: 10.1093/jac/45.4.467

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  SHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; Corinne Arpin; Laure Coulange; Cécile Bebear; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; François Demarthe; Corinne Arpin; Laure Coulange; Luciene A R Minarini; Marie-Christine Bezian; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

3.  Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.

Authors:  Amélie Carrër; Laurent Poirel; Haluk Eraksoy; A Atahan Cagatay; Selim Badur; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

Review 4.  Class 1 integron in staphylococci.

Authors:  Zhenbo Xu; Lin Li; Lei Shi; Mark E Shirtliff
Journal:  Mol Biol Rep       Date:  2011-01-22       Impact factor: 2.316

5.  CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.

Authors:  L Poirel; T Naas; I Le Thomas; A Karim; E Bingen; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome.

Authors:  Thierry Naas; Marie Zerbib; Delphine Girlich; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 7.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Cefotaxime-resistant bacteria colonizing older people admitted to an acute care hospital.

Authors:  Robert A Bonomo; Curtis J Donskey; Jeffery L Blumer; Andrea M Hujer; Claudia K Hoyenm; Michael R Jacobs; Christopher C Whalen; Robert A Salata
Journal:  J Am Geriatr Soc       Date:  2003-04       Impact factor: 5.562

9.  Isolation and Genetic Analysis of Multidrug Resistant Bacteria from Diabetic Foot Ulcers.

Authors:  Shailesh K Shahi; Ashok Kumar
Journal:  Front Microbiol       Date:  2016-01-05       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.